PMID- 30756471 OWN - NLM STAT- MEDLINE DCOM- 20191202 LR - 20221207 IS - 1751-2980 (Electronic) IS - 1751-2972 (Linking) VI - 20 IP - 4 DP - 2019 Apr TI - Circulating miR-29b positively correlates with non-alcoholic fatty liver disease in a Chinese population. PG - 189-195 LID - 10.1111/1751-2980.12716 [doi] AB - OBJECTIVE: Early screening of non-alcoholic fatty liver disease (NAFLD) is of great significance for the early detection and intervention in NAFLD. MicroRNAs (miRNAs) are important regulators of metabolic diseases including NAFLD. The aim of this study was to investigate the association of serum miR-29a-c with NAFLD in a Chinese population. METHODS: Participants were divided into four groups based on the presence or absence of NAFLD and/or type 2 diabetes mellitus (T2DM). Quantitative polymerase chain reaction analysis was performed to quantify serum level of miR-29a-c. The association of miR-29a-c with NAFLD was evaluated. RESULTS: Serum miR-29b, but not miR-29a or miR-29c, was positively associated with NAFLD (odds ratio [OR] 2.04 [1.16- 3.58], P = 0.013). Additionally, age, serum triglyceride and fasting plasma glucose (FPG) levels were independently associated with miR-29b (beta +/- standard error [SE] = 0.004 +/- 0.002, P = 0.019 for age; beta +/- SE = 0.110 +/- 0.054, P = 0.042 for triglyceride; and beta +/- SE = 0.389 +/- 0.161, P = 0.016 for FPG). MiR-29b level was positively correlated with intrahepatic lipid content (beta +/- SE = 6.055 +/- 2.630, P = 0.024) after adjusted for age, sex, and body mass index. CONCLUSIONS: Serum miR-29b was associated with intrahepatic lipid content and NAFLD in a Chinese population-based study. CI - (c) 2019 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd. FAU - He, Zhen AU - He Z AD - Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Center for Diabetes, Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China. FAU - Yang, Jian Jun AU - Yang JJ AD - Department of General Surgery, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. FAU - Zhang, Rong AU - Zhang R AD - Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Center for Diabetes, Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China. FAU - Li, Hua Ting AU - Li HT AD - Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Center for Diabetes, Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China. FAU - Wu, Liang AU - Wu L AD - Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Center for Diabetes, Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China. FAU - Jiang, Feng AU - Jiang F AD - Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Center for Diabetes, Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China. FAU - Jia, Wei Ping AU - Jia WP AD - Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Center for Diabetes, Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China. FAU - Hu, Cheng AU - Hu C AUID- ORCID: 0000-0003-4314-2386 AD - Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Center for Diabetes, Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China. AD - Department of Endocrinology and Metabolism, Institute for Metabolic Diseases, Fengxian Central Hospital, Third School of Clinical Medicine, Southern Medical University, Shanghai, China. LA - eng GR - 15ZH4006/Innovation Foundation of Translational Medicine of Shanghai Jiao Tong University School of Medicine/ GR - 2016YFC1304902/National Key Research and Development Project of China/ GR - 81570713/National Natural Science Foundation of China/ GR - National Program for Support of Top-notch Young Professionals/ GR - Shanghai Junior Doctor Training Supporting Program/ GR - Shanghai SJTUSM Biobank/ PT - Journal Article DEP - 20190403 PL - Australia TA - J Dig Dis JT - Journal of digestive diseases JID - 101302699 RN - 0 (Blood Glucose) RN - 0 (Lipids) RN - 0 (MIRN29a microRNA, human) RN - 0 (MicroRNAs) SB - IM MH - Aged MH - Asian People/genetics MH - Blood Glucose/analysis MH - Female MH - Humans MH - Lipids/blood MH - Male MH - MicroRNAs/*blood MH - Middle Aged MH - Non-alcoholic Fatty Liver Disease/*blood/genetics OTO - NOTNLM OT - circulating microRNA OT - diabetes mellitus OT - miR-29a, miR-29b, miR-29c, non-alcoholic fatty liver disease EDAT- 2019/02/14 06:00 MHDA- 2019/12/04 06:00 CRDT- 2019/02/14 06:00 PHST- 2018/06/19 00:00 [received] PHST- 2018/12/28 00:00 [revised] PHST- 2019/02/11 00:00 [accepted] PHST- 2019/02/14 06:00 [pubmed] PHST- 2019/12/04 06:00 [medline] PHST- 2019/02/14 06:00 [entrez] AID - 10.1111/1751-2980.12716 [doi] PST - ppublish SO - J Dig Dis. 2019 Apr;20(4):189-195. doi: 10.1111/1751-2980.12716. Epub 2019 Apr 3.